https://www.selleckchem.com/products/MK-1775.html
4 ± 2. in the case of non-response to an SSRI, switching to mirtazapine (7.1 ± 2.2) was recommended in the case of non-response to an SNRI, and vice versa (switching to an SNRI (7.0 ± 2. in the case of non-response to mirtazapine). Augmentation with aripiprazole was considered the first-line treatment for partial response to an SSRI (7.1 ± 2.3) or SNRI (7.0 ± 2.5). LIMITATIONS The evidence level of expert consensus is considered low. All included experts were Japanese. CONCLUSIONS Recommendations made by experts in the field are use
Like
Comment
Share
